Nuove specialità medicinali in arrivo: da Beyfortus a Opdualag, da Rosumibe a Tachipirinakid ecco i nuovi farmaci in commercio
Arrivano in farmacia diversi nuovi farmaci, da Tachipirinakid a Beyfortus fino a Rosumibe. La lista delle nuove specialità medicinali.
BEYFORTUS 1 siringa preriempita IM 1 ml 100 mg/ml + 2 aghi nirsevimab
SANOFI WINTHROP AIC:050403056 1.150,00€ C/RRL in commercio dal:08/10/2024
CARBOPLATINO AUROBINDO ITALIA 1 flaconcino EV 15 ml 10 mg/ml carboplatino
EUGIA PHARMA AIC:050777022 67,03€ H/OSP in commercio dal:16/10/2024
CARBOPLATINO AUROBINDO ITALIA 1 flaconcino EV 45 ml 10 mg/ml carboplatino
EUGIA PHARMA AIC:050777034 195,76€ H/OSP in commercio dal:16/10/2024
CARBOPLATINO AUROBINDO ITALIA 1 flaconcino EV 5 ml 10 mg/ml carboplatino
EUGIA PHARMA AIC:050777010 22,34€ H/OSP in commercio dal:16/10/2024
CARBOPLATINO AUROBINDO ITALIA 1 flaconcino EV 60 ml 10 mg/ml carboplatino
EUGIA PHARMA AIC:050777046 285,33€ H/OSP in commercio dal:18/10/2024
COLCHICINA LIRCA 60 cpr 0,5 mg colchicina
ACARPIA AIC:009964040 6,02€ A/RR in commercio dal:11/10/2024
HEMLIBRA 1 flaconcino SC 30 mg/ml 0,4 ml emicizumab
ROCHE AIC:046130062 1.378,60€ A/RRL in commercio dal:15/10/2024
OPDUALAG 1 flaconcino INFUS 240 mg + 80 mg 20 ml nivolumab/relatlimab
BRISTOL-MYERS SQUIBB AIC:050359013 10.696,03€ H/OSP in commercio dal:21/10/2024
ORSERDU 28 cpr riv 345 mg elacestrant cloridrato
STEMLINE THERAPEUTICS AIC:050896024 14.028,40€ Cnn/RNRL in commercio dal:11/10/2024
ORSERDU 28 cpr riv 86 mg elacestrant cloridrato
STEMLINE THERAPEUTICS AIC:050896012 4.676,13€ Cnn/RNRL in commercio dal:11/10/2024
ROSUMIBE 30 cpr 40 mg + 10 mg rosuvastatina sale di calcio/ezetimibe
PIAM FARMACEUTICI AIC:045350473 15,00€ A/RR in commercio dal:17/10/2024
TACHIPIRINAKID scir 120 ml 120 mg/5 ml + adattatore + siringa dosatrice paracetamolo
ANGELINI AIC:048012013 – C/ SOPin commercio dal:14/10/2024
Nuovi farmaci equivalenti
EPITIRAM orale soluz 1 flacone 150 ml 100 mg/ml con siringa dosatrice da 1 ml levetiracetam
NEURAXPHARM AIC:041122108 18,99€ A/RR in commercio dal:10/10/2024
EPITIRAM orale soluz 1 flacone 150 ml 100 mg/ml con siringa dosatrice da 3 ml levetiracetam
NEURAXPHARM AIC:041122096 18,99€ A/RR in commercio dal:10/10/2024
EPITIRAM orale soluz 1 flacone 300 ml 100 mg/ml con siringa dosatrice da 10 ml levetiracetam
NEURAXPHARM AIC:041122084 37,97€ A/RR in commercio dal:10/10/2024
OMEGA 3 SPA 30 cps molli 1.000 mg omega polienoici (esteri etilici di acidi grassi polinsaturi)
SPA (SOC.PRO.ANTIBIOTICI) AIC:046538029 12,96€ Cnn/RR in commercio dal:12/10/2024
RIVAROXABAN TEVA 10×1 cpr riv 10 mg rivaroxaban
TEVA AIC:049224102 10,37€ A/RRL in commercio dal:08/10/2024
RIVAROXABAN TEVA 28×1 cpr riv 20 mg rivaroxaban
TEVA AIC:049224328 29,02€ A/RR/RRL in commercio dal:08/10/2024
RIVAROXABAN TEVA 30×1 cpr riv 10 mg rivaroxaban
TEVA AIC:049224126 31,10€ A/RRL in commercio dal:08/10/2024
RIVAROXABAN TEVA 42×1 cpr riv 15 mg rivaroxaban
TEVA AIC:049224239 43,54€ A/RR/RRL in commercio dal:08/10/2024
SERRANOV 14 cps 25 mg pregabalin
LANOVA FARMACEUTICI AIC:050479017 1,97€ A/RR in commercio dal:15/10/2024
SERRANOV 56 cps 75 mg pregabalin
LANOVA FARMACEUTICI AIC:050479031 19,56€ A/RR in commercio dal:15/10/2024
VIDAGEST 84 cpr 2 mg dienogest
SANDOZ AIC:048681023 31,50€ A/RNR in commercio dal:14/10/2024